Prorede3 addresses excess stock and lack of medication access in Brazil by providing a solution that allows pharmaceutical companies the donation of medications.

Prorede3 addresses the issue of excess stock and lack of medication access in Brazil by offering a unique solution that enables pharmaceutical companies to donate medications. Recognising the significant amount of unused medicines being discarded due to short expiration dates, coupled with the widespread lack of access to healthcare among vulnerable populations in Brazil, Prorede3 saw an opportunity to bridge this gap. 

They observed that while pharmaceutical companies were willing to donate excess stock, the heavy taxation on donations acted as a disincentive. In response to this socio-environmental challenge, Prorede3 developed an innovative approach. They encourage pharmaceutical companies to donate medicines to vulnerable communities through reputable philanthropic entities, offering media bonuses in idle advertising spaces as an incentive.